CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-01-23 | Buchbinder Aby VP, Clinical Development | Grant or award | +3,748 | 79,246 | ||
| 2012-01-17 | Buchbinder Aby VP, Clinical Development | Grant or award | +4,000 | 58,015 | ||
| 2012-01-17 | Buchbinder Aby VP, Clinical Development | Grant or award · Employee Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2011-11-08 | Buchbinder Aby VP, Clinical Development | Sale | −2,700 | $7.06 | $19K | 54,015 |
| 2011-09-15 | Buchbinder Aby VP, Clinical Development | Shares withheld for taxes | −2,952 | $8.33 | $25K | 56,715 |
| 2011-08-12 | Buchbinder Aby VP, Clinical Development | Grant or award | +8,000 | 59,667 |
Page 1 of 1 · 6 trades